NYSE:SYK - Stryker Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $184.31 +0.17 (+0.09 %) (As of 05/21/2019 01:14 AM ET)Previous Close$184.14Today's Range$182.69 - $184.9052-Week Range$144.75 - $199.85Volume758,909 shsAverage Volume1.37 million shsMarket Capitalization$68.77 billionP/E Ratio25.21Dividend Yield1.13%Beta0.84 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Receive SYK News and Ratings via Email Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:SYK Previous Symbol CUSIP86366710 CIK310764 Webwww.strykercorp.com Phone269-389-2600Debt Debt-to-Equity Ratio0.68 Current Ratio2.12 Quick Ratio1.30Price-To-Earnings Trailing P/E Ratio25.21 Forward P/E Ratio22.61 P/E Growth2.24 Sales & Book Value Annual Sales$13.60 billion Price / Sales5.06 Cash Flow$9.3653 per share Price / Cash Flow19.68 Book Value$31.34 per share Price / Book5.88Profitability EPS (Most Recent Fiscal Year)$7.31 Net Income$3.55 billion Net Margins25.38% Return on Equity26.72% Return on Assets11.80%Miscellaneous Employees36,000 Outstanding Shares373,105,000Market Cap$68.77 billion Next Earnings Date7/23/2019 (Estimated) OptionableOptionable Stryker (NYSE:SYK) Frequently Asked Questions What is Stryker's stock symbol? Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK." How often does Stryker pay dividends? What is the dividend yield for Stryker? Stryker announced a quarterly dividend on Wednesday, May 1st. Stockholders of record on Friday, June 28th will be given a dividend of $0.52 per share on Wednesday, July 31st. This represents a $2.08 annualized dividend and a dividend yield of 1.13%. The ex-dividend date is Thursday, June 27th. View Stryker's Dividend History. How were Stryker's earnings last quarter? Stryker Co. (NYSE:SYK) issued its quarterly earnings data on Tuesday, April, 23rd. The medical technology company reported $1.88 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.84 by $0.04. The medical technology company had revenue of $3.52 billion for the quarter, compared to analysts' expectations of $3.51 billion. Stryker had a net margin of 25.38% and a return on equity of 26.72%. The firm's revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.68 EPS. View Stryker's Earnings History. When is Stryker's next earnings date? Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, July 23rd 2019. View Earnings Estimates for Stryker. What guidance has Stryker issued on next quarter's earnings? Stryker issued an update on its FY19 earnings guidance on Tuesday, April, 23rd. The company provided earnings per share (EPS) guidance of $8.05-8.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.13. Stryker also updated its FY 2019 guidance to $8.05-8.20 EPS. What price target have analysts set for SYK? 21 analysts have issued 1-year target prices for Stryker's stock. Their forecasts range from $156.75 to $219.00. On average, they anticipate Stryker's stock price to reach $196.2875 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price. View Analyst Price Targets for Stryker. What is the consensus analysts' recommendation for Stryker? 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker. Has Stryker been receiving favorable news coverage? News articles about SYK stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stryker earned a coverage optimism score of -1.6 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. Who are some of Stryker's key competitors? Some companies that are related to Stryker include 3M (MMM), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), ABIOMED (ABMD), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Novocure (NVCR) and ICU Medical (ICUI). What other stocks do shareholders of Stryker own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Home Depot (HD), Abbott Laboratories (ABT), Bank of America (BAC), General Electric (ge), AbbVie (ABBV), Celgene (CELG), Visa (v), CVS Health (CVS) and UnitedHealth Group (UNH). Who are Stryker's key executives? Stryker's management team includes the folowing people: Mr. Kevin A. Lobo, Chairman & CEO (Age 54)Mr. Timothy J. Scannell, Pres & COO (Age 54)Mr. Glenn S. Boehnlein, VP & CFO (Age 57)Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57) Who are Stryker's major shareholders? Stryker's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.71%), Greenleaf Trust (5.96%), FMR LLC (1.80%), Fundsmith LLP (1.50%), Northern Trust Corp (1.05%) and Geode Capital Management LLC (1.04%). Company insiders that own Stryker stock include Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker. Which institutional investors are selling Stryker stock? SYK stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Greenleaf Trust, Lazard Asset Management LLC, California Public Employees Retirement System, AQR Capital Management LLC, Janus Henderson Group PLC, Pictet Asset Management Ltd. and Westpac Banking Corp. Company insiders that have sold Stryker company stock in the last year include Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker. Which institutional investors are buying Stryker stock? SYK stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Ellis Investment Partners LLC, Geode Capital Management LLC, GQG Partners LLC, State Treasurer State of Michigan, Teacher Retirement System of Texas, BlackRock Inc. and Ferguson Wellman Capital Management Inc.. View Insider Buying and Selling for Stryker. How do I buy shares of Stryker? Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Stryker's stock price today? One share of SYK stock can currently be purchased for approximately $184.31. How big of a company is Stryker? Stryker has a market capitalization of $68.77 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe. What is Stryker's official website? The official website for Stryker is http://www.strykercorp.com. How can I contact Stryker? Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected] MarketBeat Community Rating for Stryker (NYSE SYK)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 684 (Vote Outperform)Underperform Votes: 676 (Vote Underperform)Total Votes: 1,360MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: What are gap-up stocks? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.